Immunology - Rapid Biomimetic Nanovaccine for Personalized Cancer Therapy
View as a Web Page
News Medical
 
  Immunology Immunology logo  
  The latest immunology news from News Medical  
 

Pipettes help progress small molecule inhibitorsPipettes help progress small molecule inhibitors

RAPT Therapeutics in San Francisco, USA, relies on INTEGRA Biosciences’ pipettes to seamlessly accelerate the development of its candidate small molecule inhibitors for the treatment of inflammatory diseases and cancers.

Get the full story
 
   Rapid Biomimetic Nanovaccine for Personalized Cancer TherapyRapid Biomimetic Nanovaccine for Personalized Cancer Therapy
 
Breakthrough nanovaccine uses tumor cell membranes and immune-boosting polymers to enhance personalized cancer immunotherapy, showing strong results in preclinical models.
 
   Optimizing Antigen Density on Gold Nanoparticles for Cancer VaccinesOptimizing Antigen Density on Gold Nanoparticles for Cancer Vaccines
 
A study in Chemistry A European Journal reveals that reduced MUC1 antigen density on gold nanoparticles still elicits potent tumor-specific immune responses, supporting flexible cancer vaccine design strategies.
 
 Inhalable Nanovaccines: The Future of Needle-Free Immunization
 
Inhalable Nanovaccines: The Future of Needle-Free ImmunizationInhalable nanovaccines offer needle-free, mucosal immunity against respiratory diseases like COVID-19, influenza, and TB. Explore delivery mechanisms, key technologies, and future breakthroughs.
 
 
 Scientists enhance T cell immunity for more durable vaccines
 
Scientists enhance T cell immunity for more durable vaccinesWEHI scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines for viruses and enhanced cancer therapies.
 
 
 Macrophages take center stage in liver healing after injury
 
Macrophages take center stage in liver healing after injuryThe liver is famous for its remarkable ability to regenerate, but that healing power depends heavily on the actions of its resident immune cells. A new study spotlights macrophages, the liver's cleanup and repair specialists, revealing that these cells quickly adapt after injury to clear debris and support tissue recovery.
 
 
 Next-generation "armored" CAR T cell therapy shows promising results in lymphoma patients
 
Next-generation "armored" CAR T cell therapy shows promising results in lymphoma patientsA next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including commercially available CAR T cell therapies.
 
 

How would you rate today's newsletter?

 
             
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025